Less Ads, More Data, More Tools Register for FREE

Director dealings: Diurnal trio dip in after EMA submission in December

Mon, 16th Jan 2017 15:08

(ShareCast News) - A trio of Diurnal Group directors bought shares in the hormone disease specialist, which remain little higher than the low reached late last year.Chairman Peter Allen bought 40,000 shares at 105p and non-executive directors Sam Williams and John Goddard bought 9,248 each at a price of 108p.Diurnal, which floated on AIM in December 2015 market authorisation in late 2017, last month submitted the marketing application to the European Medicines Agency for Infacort, which has the potential to be the first licensed treatment in Europe for Adrenal Insufficiency (AI) specifically designed for use in children under six years of age.This was made on the back of "highly statistically significant" data from clinical trials, with the EMA having already approved a paediatric investigation plan (PIP) for Infacort that set out the regulatory pathway to market authorisation.Diurnal anticipates market authorisation in late 2017, with product revenues expected from early 2018 and the company estimating the total market for paediatric AI and the related condition Congenital Adrenal Hyperplasia in Europe is approximately $28m per year.Top Director BuysDiurnal Group (DNL)Director name: Allen,PeterAmount purchased: 40,000 @ 105.00pValue: £42,000.00Diurnal Group (DNL)Director name: Goddard,JohnAmount purchased: 9,248 @ 108.00pValue: £9,987.84Diurnal Group (DNL)Director name: Williams,SamAmount purchased: 9,248 @ 108.00pValue: £9,987.84Jardine Lloyd Thompson Group (JLT)Director name: Walsh,NicholasAmount purchased: 1,000 @ 997.42pValue: £9,974.25Haydale Graphene Industries (HAYD)Director name: Gibbs,Raymond (Ray) JohnAmount purchased: 4,353 @ 160.00pValue: £6,964.80Fidelity Asian Values (FAS)Director name: Stott,GrahameAmount purchased: 4,000 @ 31.00pValue: £1,240.00Vodafone Group (VOD)Director name: Schellekens,Ronald Amount purchased: 118 @ 212.45pValue: £250.69Sthree (STHR)Director name: Smith,AlexAmount purchased: 65 @ 319.00pValue: £207.35Sthree (STHR)Director name: Elden,GaryAmount purchased: 64 @ 319.00pValue: £204.16Supergroup (SGP)Director name: Sutherland ,EuanAmount purchased: 9 @ 1,712.00pValue: £154.08Supergroup (SGP)Director name: Cartwright,Andrea Amount purchased: 9 @ 1,712.00pValue: £154.08Aviva (AV.)Director name: Amin,NitinbhaiAmount purchased: 31 @ 480.80pValue: £149.05Shoe Zone (SHOE)Director name: Davis ,Nicholas (Nick)Amount purchased: 7,000 @ 1.80pValue: £126.00Top Director SellsRenew Holdings (RNWH)Director name: Samuel,JohnAmount sold: 112,518 @ 434.00pValue: £488,328.14Lindsell Train Inv Trust (LTI)Director name: Landman,RoryAmount sold: 100 @ 86,500.00pValue: £86,500.00

Related Shares

More News
28 Oct 2022 21:18

TRADING UPDATES: SulNOx, Marwyn loss widens; Kropz gets new facility

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

21 Oct 2022 21:29

TRADING UPDATES: Trackwise Designs wins deal; Cake Box names CFO

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

14 Oct 2022 15:48

UK shareholder meetings calendar - next 7 days

7 Oct 2022 13:01

Diurnal treatment gets approval from Welsh regulatory body

(Alliance News) - Diurnal Group PLC on Friday said its Efmody treatment has been recommended as an option to treat patients with congenital adrenal hy...

7 Oct 2022 11:31

Diurnal's 'Efmody' treatment gets thumbs-up for NHS Wales

(Sharecast News) - Specialty pharmaceutical company Diurnal Group announced on Friday that the All-Wales Medicines Strategy Group (AWMSG) has recommen...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.